Bupivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Kindos Pharmaceuticals Co. Ltd.

The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Kindos Pharmaceuticals Co. Ltd. with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Kindos Pharmaceuticals Co. Ltd.
Package NDC
71288-723-52
Dosage Form
Injection
Presentation
Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)
Initial Posting
Feb 20, 2018

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.